Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Deferred Revenue

$1.68M

Quarterly · Period ending: Jun 30, 2026 · USD

LCTX Deferred Revenue

Latest reported$1.68Mperiod endingJun 30, 2026

Latest reported$1.68Mperiod endingJun 30, 2026

LCTX Quarterly Deferred Revenue ($0.00 → $1.68M)

Quarterly deferred revenue

High-resolution chart · PNG

LCTX deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Deferred Revenue — Quarterly (USD)
Period ending	Deferred Revenue (USD)
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	0
Sep 30, 2000	0
Jun 30, 2000	0
Mar 31, 2000	0
Dec 31, 1999	0
Sep 30, 1999	0
Jun 30, 1999	0
Mar 31, 1999	0
Sep 30, 1998	0
Jun 30, 1998	0
Mar 31, 1998	0
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.